BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 32930662)

  • 1. Mutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races.
    Tenthorey JL; Young C; Sodeinde A; Emerman M; Malik HS
    Elife; 2020 Sep; 9():. PubMed ID: 32930662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Capsids to Complexes: Expanding the Role of TRIM5α in the Restriction of Divergent RNA Viruses and Elements.
    Rose KM; Spada SJ; Broeckel R; McNally KL; Hirsch VM; Best SM; Bouamr F
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33801908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
    Oliveira NM; Trikha R; McKnight Á
    Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human TRIM5α: Autophagy Connects Cell-Intrinsic HIV-1 Restriction and Innate Immune Sensor Functioning.
    Cloherty APM; Rader AG; Compeer B; Ribeiro CMS
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33669846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
    Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
    Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-canonical role for the autophagy machinery in anti-retroviral signaling mediated by TRIM5α.
    Saha B; Chisholm D; Kell AM; Mandell MA
    PLoS Pathog; 2020 Oct; 16(10):e1009017. PubMed ID: 33052966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assisted evolution enables HIV-1 to overcome a high TRIM5α-imposed genetic barrier to rhesus macaque tropism.
    Soll SJ; Wilson SJ; Kutluay SB; Hatziioannou T; Bieniasz PD
    PLoS Pathog; 2013; 9(9):e1003667. PubMed ID: 24086139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
    Rold CJ; Aiken C
    PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The control of viral infection by tripartite motif proteins and cyclophilin A.
    Towers GJ
    Retrovirology; 2007 Jun; 4():40. PubMed ID: 17565686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques.
    Wu F; Ourmanov I; Riddick N; Matsuda K; Whitted S; Plishka RJ; Buckler-White A; Starost MF; Hirsch VM
    J Virol; 2015 Feb; 89(4):2233-40. PubMed ID: 25473059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles.
    Ylinen LM; Keckesova Z; Wilson SJ; Ranasinghe S; Towers GJ
    J Virol; 2005 Sep; 79(18):11580-7. PubMed ID: 16140735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor.
    Twentyman J; Khalifeh A; Felton AL; Emerman M; OhAinle M
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
    Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor.
    Twentyman J; Khalifeh A; Felton AL; Emerman M; Ohainle M
    Retrovirology; 2023 Aug; 20(1):15. PubMed ID: 37608289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain-of-sensitivity mutations in a Trim5-resistant primary isolate of pathogenic SIV identify two independent conserved determinants of Trim5α specificity.
    McCarthy KR; Schmidt AG; Kirmaier A; Wyand AL; Newman RM; Johnson WE
    PLoS Pathog; 2013 May; 9(5):e1003352. PubMed ID: 23675300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner.
    Ohainle M; Kim K; Komurlu Keceli S; Felton A; Campbell E; Luban J; Emerman M
    PLoS Pathog; 2020 Apr; 16(4):e1008507. PubMed ID: 32282853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophilin A protects HIV-1 from restriction by human TRIM5α.
    Kim K; Dauphin A; Komurlu S; McCauley SM; Yurkovetskiy L; Carbone C; Diehl WE; Strambio-De-Castillia C; Campbell EM; Luban J
    Nat Microbiol; 2019 Dec; 4(12):2044-2051. PubMed ID: 31636416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.
    Ohmine S; Sakuma R; Sakuma T; Thatava T; Takeuchi H; Ikeda Y
    PLoS One; 2011 Jan; 6(1):e16121. PubMed ID: 21264255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.